A Structured School-based Health Intervention for the Obesity Prevention
Launched by UNIVERSITI PUTRA MALAYSIA · Aug 7, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on finding ways to help prevent obesity in children. The researchers are testing a structured program that teaches kids and their families about healthy eating and the importance of physical activity. By providing education through schools, the program aims to raise awareness about the risks of obesity and encourage better food choices among children aged 5 to 12 years.
To participate in this study, children must be enrolled in one of the selected schools and be between 5 to 12 years old. Parents will need to agree to let their children take part. While the trial is not yet recruiting participants, it promises a supportive approach to promoting healthier habits for kids and their families.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children of age between 5 to 12 years.
- • Enrollment at one of the selected schools.
- Exclusion Criteria:
- • Children and their parents who did not give assent and consent to participate in the study.
About Universiti Putra Malaysia
Universiti Putra Malaysia (UPM) is a prestigious research university located in Malaysia, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, UPM leverages its extensive academic resources and expertise to conduct rigorous research aimed at improving patient outcomes and contributing to the global body of medical knowledge. The university fosters collaboration among multidisciplinary teams, ensuring that its clinical trials adhere to the highest ethical and regulatory standards while addressing critical health challenges. Through its initiatives, UPM plays a vital role in translating scientific findings into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nawab Shah, Sindh, Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported